EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.14.14.37 | Acquired Immunodeficiency Syndrome |
30158872 |
NADPH-Cytochrome P450 Reductase Mediates the Resistance of Aphis (Toxoptera) citricidus (Kirkaldy) to Abamectin. |
therapeutic application
unassigned |
1
0 |
| 1.14.14.37 | Adenoma |
8496319 |
High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens. |
diagnostic usage
ongoing research
unassigned |
4
2
0 |
| 1.14.14.37 | Adrenal Hyperplasia, Congenital |
19884324 |
Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. |
causal interaction
ongoing research
unassigned |
2
1
0 |
| 1.14.14.37 | Adrenocortical Adenoma |
8496319 |
High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens. |
diagnostic usage
ongoing research
unassigned |
4
2
0 |
| 1.14.14.37 | Breast Neoplasms |
14583491 |
Human NADPH-cytochrome p450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 1.14.14.37 | Breast Neoplasms |
19956630 |
Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
3
4 |
| 1.14.14.37 | Carcinogenesis |
2119905 |
The levels of quinone reductases, superoxide dismutase and glutathione-related enzymatic activities in diethylstilbestrol-induced carcinogenesis in the kidney of male Syrian golden hamsters. |
causal interaction
unassigned |
1
0 |
| 1.14.14.37 | Carcinoma, Hepatocellular |
10333489 |
Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. |
therapeutic application
unassigned |
1
0 |
| 1.14.14.37 | Carcinoma, Hepatocellular |
16214121 |
The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase. |
ongoing research
unassigned |
4
0 |
| 1.14.14.37 | Cardiotoxicity |
18463197 |
Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. |
ongoing research
therapeutic application
unassigned |
3
3
0 |
